The latest news from academia, regulators
research labs and other things of interest
Posted: January 7, 2009
NanoGuardian's New Web Site Offers Information and Solutions to Fight Counterfeiting of Pharmaceuticals
(Nanowerk News) NanoGuardian™, a division of NanoInk®, launched a new Web site today, which is dedicated to providing useful information and resources to fight illegal diversion and counterfeiting of pharmaceuticals. The new Web site, www.nanoguardian.net, also provides detailed information on NanoGuardian's state-of-the-art, on-dose brand protection solution, NanoEncryption™ technology and NanoGuardian's proactive market-monitoring program, Closed-Loop Protection™.
"The new NanoGuardian Web site is a resource for those in government, law enforcement and any industry that is affected by illegal counterfeiting and diversion of its products," said Dean Hart, executive vice president of NanoGuardian. "We also encourage visitors to learn about our novel NanoEncryption technology, which is the only on-dose, multi-layered, brand protection solution that enables pharmaceutical manufacturers to trace and authenticate every single dose from plant to patient. Complementing our NanoEncryption technology is our Closed-Loop Protection market-monitoring program, which serves as an early warning system to manufacturers in the detection of counterfeit and diverted product."
The Web site also provides continuous updates on new reports of counterfeited and illegally diverted products in the marketplace as well as past press releases and news articles.
NanoGuardian™, a division of NanoInk®, focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. NanoGuardian's cutting-edge NanoEncryption™ technology enables manufacturers to authenticate and trace the integrity of their products across the supply chain. More information about NanoGuardian is available at www.nanoguardian.net.